1. Ishihara BP, Farah D, Fonseca MCM, Nazario A. The risk of developing breast, ovarian, and endometrial cancer in obese women submitted to bariatric surgery: a meta-analysis. Surg Obes Relat Dis. 2020 Oct;16(10):1596–602.<!–Q1: last-page details fetched from PubMed–>
2. Yadav S, Hu C, Hart SN, Boddicker N, Polley EC, Na J, et al. Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer. J Clin Oncol. 2020;38:1409–18.13<!–Q2: author4surname, author4initial, author5surname, author5initial, author6surname, author6initial, stl, last-page details fetched from PubMed–>
3. Tung NM, Robson ME, Ventz S, Santa-Maria CA, Nanda R, Marcom PK, et al. TBCRC 048: Phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes. J Clin Oncol. 2020 Dec;38(36):4274–82.<!–Q3: first-page, last-page details fetched from PubMed–>
4. Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, et al. Breast cancer risk genes – association analysis in more than 113,000 Women. N Engl J Med. 2021 Feb;384(5):428–39.<!–Q4: author2surname, author2initial, author3surname, author3initial, author4surname, author4initial, author5surname, author5initial, author6surname, last-page details fetched from PubMed–>
5. Co M, Liu T, Leung J, Li CH, Tse T, Wong M, et al. Breast conserving surgery for BRCA mutation carriers – a systematic review. Clin Breast Cancer. 2020 Jun;20(3):e244–50.<!–Q5: last-page details fetched from PubMed–>